Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bristol-Myers Squibb Co BMY

Healthcare
Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule... see more

Recent & Breaking News (NYSE:BMY)

Sub-Group Analysis Shows Investigational Metreleptin Treatment Demonstrated Reductions in HbA1c, Triglycerides and Liver Function Tests in Pediatric Patients with Lipodystrophy During a 12-Month Period

Business Wire May 6, 2013

Ambrx Initiates Collaboration with Bristol-Myers Squibb for Discovery, Development of Next-Generation Antibody Drug Conjugates

PR Newswire May 3, 2013

Before the Crowd, How We Found HD, EXC, DD and BMY

Marketwired May 2, 2013

The Real Story Behind TWC, NWSA, COF and BMY

Marketwired April 30, 2013

BMY, LLY, ENDP, and AGN Early Briefing and Review

Accesswire April 30, 2013

Key to Success, How to Profit: GILD, BMY, EBAY and FFIV

Marketwired April 26, 2013

Bristol-Myers Squibb Reports First Quarter 2013 Financial Results

Business Wire April 25, 2013

Former Pro Football Coach Bill Cowher Tells Men "No Excuses" When It Comes to Getting Screened for Melanoma

Business Wire April 23, 2013

Former Pro Football Coach Bill Cowher Tells Men "No Excuses" When It Comes To Getting Screened For Melanoma

PR Newswire April 23, 2013

High Rates of SVR Demonstrated in Phase II Study with Investigational Triple DAA Regimen of Daclatasvir, Asunaprevir and BMS-791325 in Treatment-Naïve Patients with Genotype 1 Chronic Hepatitis C Infection

Business Wire April 23, 2013

High Rates of SVR Demonstrated in Phase II Study with Investigational Triple DAA Regimen of Daclatasvir, Asunaprevir and BMS-791325 in Treatment-Naïve Patients with Genotype 1 Chronic Hepatitis C Infection

Canada NewsWire April 23, 2013

Bristol-Myers Squibb Funds Green Schools Fellowship to Help New Jersey School Districts Create Healthier, More Sustainable Learning Environments

Business Wire April 22, 2013

Santaris Pharma announces a worldwide discovery alliance with Bristol-Myers Squibb for RNA-targeted medicines

PR Newswire April 16, 2013

Perfect Trade Setups, How to Play COH, BMY, CELG and CLF

Marketwired April 15, 2013

The Real Story Behind NOK, UTX, CELG and BMY

Marketwired April 12, 2013

Bristol-Myers Squibb to Expand Massachusetts Biologics Facility

Business Wire April 11, 2013

Bristol-Myers Squibb Foundation, Morehouse School of Medicine Partner to Spread Lessons from Together on Diabetes(TM) Initiative

Business Wire April 10, 2013

Secrets to Making Money in TWC, PEP, CVS and BMY

Marketwired April 10, 2013

Bristol-Myers Squibb to Present New Data on Hepatitis C and Hepatitis B Compounds at The International Liver CongressTM (ILC) 2013

Business Wire April 8, 2013

Strategy Behind Our Success, We Get in Early: LNKD, BMY, MON and MPC

Marketwired April 8, 2013